Kamada Ltd. Announces Pre-Close Brief Ahead of August 13, 2025, Conference Call to Discuss Q2 and First Half Financial Results
Kamada Ltd. will release its Q2 and first half financial results for 2025 on August 13, 2025, before U.S. market opening. A conference call will follow at 8:30am ET for discussion and Q&A. Interested participants can join via phone or webcast. This announcement was published via EDGAR by the U.S. SEC.
Kamada Ltd., a global biopharmaceutical company specializing in specialty plasma-derived products, has announced that it will release its financial results for the second quarter and first half ended June 30, 2025. The announcement is scheduled to occur prior to the opening of the U.S. financial markets on Wednesday, August 13, 2025. In conjunction with the release, Kamada management will host a conference call at 8:30am Eastern Time on the same day to discuss the results and field questions from participants. Interested parties can join the call by dialing the provided numbers or accessing the webcast online. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kamada Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-072304), on August 06, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
